Alto Neuroscience Ownership | Who Owns Alto Neuroscience?
Alto Neuroscience Ownership Summary
Alto Neuroscience is owned by 90.94% institutional investors, 4.12% insiders, and 4.94% retail investors. Commodore capital lp is the largest institutional shareholder, holding 9.44% of ANRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.17% of its assets in Alto Neuroscience shares.
ANRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alto Neuroscience | 90.94% | 4.12% | 4.94% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Commodore capital lp | 2.72M | 9.44% | $61.22M |
| Alpha wave global, lp | 3.71M | 8.66% | $94.66M |
| Vestal point capital, lp | 2.06M | 7.15% | $46.40M |
| Perceptive advisors | 2.01M | 6.97% | $45.18M |
| Blackrock funding, inc. /de | 2.73M | 6.37% | $69.60M |
| Vanguard group | 1.37M | 5.04% | $24.31M |
| Vanguard capital management | 1.69M | 3.95% | $43.16M |
| Spruce street capital lp | 1.68M | 3.92% | $42.80M |
| Vivo capital | 1.36M | 3.18% | $34.72M |
| Armistice capital | 912.00K | 3.16% | $20.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 72 investment | 667.78K | 30.26% | $15.01M |
| Spruce street capital lp | 1.68M | 6.80% | $42.80M |
| Vivo capital | 1.36M | 3.82% | $34.72M |
| Commodore capital lp | 2.72M | 3.54% | $61.22M |
| Alpha wave global, lp | 3.71M | 2.22% | $94.66M |
| Vestal point capital, lp | 2.06M | 1.30% | $46.40M |
| Ikarian capital | 515.00K | 0.94% | $11.58M |
| Perceptive advisors | 2.01M | 0.88% | $45.18M |
| Affinity asset advisors | 643.34K | 0.67% | $16.42M |
| Integral health asset management | 500.00K | 0.54% | $11.24M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | 2.72M | 3.54% | 900.00K |
| Marshall wace, llp | 859.31K | 0.02% | 633.81K |
| Blackrock funding, inc. /de | 2.73M | 0.00% | 605.10K |
| Vr adviser | 500.00K | 0.42% | 500.00K |
| Eventide asset management | 425.00K | 0.15% | 425.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 503.09K | 0.01% | -1.10M |
| Armistice capital | 912.00K | 0.36% | -624.00K |
| Vestal point capital, lp | 2.06M | 1.30% | -420.93K |
| Jennison associates | - | - | -386.43K |
| Woodline partners lp | - | - | -359.87K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vr adviser | 500.00K | 0.42% | 500.00K | $11.24M |
| Eventide asset management | 425.00K | 0.15% | 425.00K | $10.85M |
| Adage capital partners gp | 385.00K | 0.01% | 385.00K | $8.65M |
| Eversept partners, lp | 125.17K | 0.15% | 125.17K | $2.81M |
| Saturn v capital management | 89.00K | 0.36% | 89.00K | $2.00M |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -110.00 |
| True wealth design | -126.00 |
| North star investment management | -174.00 |
| Nelson, van denburg & campbell wealth management group | -249.00 |
| Physician wealth advisors | -377.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 137 | 14.17% | 38,935,422 | 31.76% | 90 | 1.91% | 94 | 36.23% | 25 | -13.79% |
| Jun 30, 2026 | 120 | 5.26% | 29,560,330 | 10.17% | 69 | 1.04% | 69 | 32.69% | 29 | -34.09% |
| Mar 31, 2026 | 113 | 11.88% | 26,804,540 | 8.52% | 92 | 1.12% | 52 | -10.34% | 43 | 72.00% |
| Dec 31, 2025 | 18 | -76.62% | 1,951,777 | -88.35% | 7 | 0.19% | 10 | -60.00% | 4 | -85.19% |
| Sep 30, 2025 | 17 | -78.48% | 1,494,416 | -91.36% | 5 | 0.14% | 9 | -78.57% | 5 | -76.19% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.01M | 3.17% | 136.10K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.21M | 3.07% | 193.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.01M | 2.60% | 136.10K |
| iShares Russell 2000 ETF | 813.87K | 2.07% | - |
| Franklin Biotechnology Discv A(acc)USD | 645.53K | 1.65% | - |
| T. Rowe Price Health Sciences | 500.85K | 1.28% | 500.85K |
| Vanguard Institutional Extnd Mkt Idx Tr | 347.15K | 0.99% | 624.00 |
| Franklin Biotechnology Discovery A | 347.90K | 0.89% | - |
| iShares Russell 2000 Growth ETF | 299.03K | 0.76% | -1.13K |
| Fidelity Small Cap Index | 287.03K | 0.73% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Sell | $78.39K |
| Nov 16, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Sell | $1.55M |
| Nov 16, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Sell | $309.71K |
| Nov 18, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Sell | $76.69K |
| Nov 17, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | Sell | $56.42K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 5 |
| 2026 Q3 | - | 3 |
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
ANRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools